Evidence map›Paper›PMID 33434096›Full record

ArticleHealth security

Respiratory Protection in a Time of Crisis: NIOSH Testing of International Respiratory Protective Devices for Emergency Use.

Angela S Andrews, John R Powers, Jaclyn K Cichowicz, Christopher C Coffey, Marisa L Fries, Patrick L Yorio, Maryann M D'Alessandro

Open access · hybridAbstract read
In one paragraph

Article in Health security. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Respiratory Protection: Lessons Learned from a Global Pandemic.Risk management and healthcare policy · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Angela S AndrewsAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
John R PowersAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
Jaclyn K CichowiczAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
Christopher C CoffeyAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
Marisa L FriesAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
Patrick L YorioAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
Maryann M D'AlessandroAngela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
National Institute for Occupational Safety and Health · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

National Institute for Occupational Safety and Health (NIOSH)-approved respirators are required by the Occupational Safety and Health Administration (OSHA) when personal respiratory protection is used in US occupational settings. During the COVID-19 pandemic, the demand for NIOSH-approved N95 filtering facepiece respirators overwhelmed the available supply. To supplement the national inventory of N95 respirators, contingency and crisis capacity strategies were implemented and incorporated a component that endorsed the use of non-NIOSH-approved respiratory protective devices that conformed to select international standards. The development and execution of this strategy required the collaborative effort of numerous agencies. The Food and Drug Administration temporarily authorized non-NIOSH-approved international respiratory protective devices through an emergency use authorization, OSHA relaxed their enforcement guidance concerning their use in US workplaces, and NIOSH initiated a supplemental performance assessment process to verify the quality of international devices. NIOSH testing revealed that many of the non-NIOSH-approved respiratory protective devices had filtration efficiencies below 95% and substantial inconsistencies in filtration performance. This article reports the results of the NIOSH testing to date and discusses how it has contributed to continuous improvement of the crisis strategy of temporarily permitting the use of non-NIOSH-approved respirators in US occupational settings during the COVID-19 pandemic.

Indexed as

COVID-19Public HealthEnvironmental HealthFiltrationHumansInternationalityNational Institute for Occupational Safety and Health, U.S.Occupational ExposureRespiratory Protective DevicesUnited StatesCOVID-19Epidemic management/responseNational strategy/policyPersonal protective equipmentPublic health preparedness/response

Identifiers

PMID33434096
PMCPMC8906491
OpenAlexW3119584388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.